A look at some of the highlights from Proactive Investors US and Canada Newswire Day
Co-Diagnostics (NASDAQ: CODX) Inc announced that it has completed the acquisition of Idaho Molecular Inc and Advanced Conception Inc to provide the company with all existing and future assets and intellectual property related to its upcoming home diagnosis / at the point of service. device. The transaction settled for 4.72 million shares of Co-Diagnostics (NASDAQ: CODX) and additional common warrants totaling 465,000. The Salt Lake City, Utah-based company said the The acquisition is expected to streamline the commercialization of the Eikon platform and YourTest PCR device as it nears completion. The device was designed with highly specialized optics to accommodate multiplexed testing as the company expands its future Eikon product line to include additional respiratory and other infectious diseases using its patented CoPrimer technology, the company said. .
BioPorto (NASDAQ COPENHAG: BIOPOR) A / S said it exercised its current authorization by issuing 12.6 million warrants to key employees and senior management of the company. Each warrant grants its holder the right to subscribe to one share of BioPorto (NASDAQ COPENHAG: BIOPOR). The exercise price is DKK 2.47 per share. Warrants generally vest over a period of four years. Warrants include recovery conditions in the event of events such as incorrect financial information and provisions on accelerated acquisition in the event of, for example, a takeover bid and / or business combinations, and in this which concerns a total of 1,700,000 warrants, on US Food & Drug Administration Approval of the NGAL test for pediatric use.
Organic Garage (TSX-V: OG) Ltd has released its 3Q 2021 results which show its gross profit margins have increased despite inflationary pressures and supply chain issues faced by many retailers this year. According to Organic Garage (TSX- V: OG). The gross profit margin, however, fell from 30.4% to 31.3%.
Jack Nathan Medical Corp (Jack Nathan Health) revealed a 143% increase in revenue from its fiscal third quarter results as its clinical operations ramp up. The healthcare company reported total third quarter revenue of C $ 2.4 million, a jump from the nearly $ 1 million reported in the comparable three-month period ended 31 October of last year. In a statement accompanying the results, Jack Nathan attributed the increase in revenue to “high clinic operating revenues from acquisitions and organic growth in Canada, including rehabilitation services and MedSpa, in Canada, and new clinics and medical services in Mexico â.
Empower Clinics Inc announced that its subsidiary The Medi-Collective (TMC) has opened a new clinic in London, Ontario. The clinic is accepting new patients from December 31, 2021, the company said. The company said the completely renovated 3,400 square foot site will offer family medicine, teledermatology and paramedical services such as chiropractors, physiotherapy, registered massage therapists and custom orthopedic orthotics. The staff currently has five family physicians and plans to hire general practitioners and specialists to provide additional services in the coming months. Medical support staff are equipped through Empower’s partnership with MedX Health Corporation to facilitate teledermatology appointments. âOur team has made immense progress in growing our footprint this year despite the operational and logistical challenges brought on by the pandemic and the supply chain crisis,â said Steven McAuley, CEO of Empower, in a statement.
Helix BioPharma Corp called 2021 a “productive year” in a year-end update to shareholders. The Richmond Hill, Ontario-based company is a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology for the prevention and treatment of cancer based on its proprietary DOS47 technology platform. During the second half of 2021, the company embarked on efforts to validate its primary clinical program with external stakeholders to bring an outside perspective on the strategy and future of the company, the company said. âOur clinical program remains our top priority to ensure we deliver a substantial data set that would ultimately benefit patients and stakeholders. We are awaiting final trial reports from Phase I and II studies in lung cancer in 2022, âsaid Slawomir Majewski, Interim CEO.
BioPorto (NASDAQ COPENHAG: BIOPOR) A / S said it is supporting Rigshospitalet (RH (NYSE: RH)), Copenhagen, with quantitative thrombomodulin testing based on its generic Rapid Assay Device (gRAD) technology. RH (NYSE: RH) is investigating the possibility of using blood thrombomodulin levels as a marker in patients with sepsis to indicate who might benefit from treatment with the drug prostacyclin. It is currently summarizing the findings of its feasibility study and plans to publish the results once its assessment is complete. BioPorto (NASDAQ COPENHAG: BIOPOR) said it is also using the gRAD platform in a feasibility study to detect SARS-CoV-2, the virus that causes the coronavirus (COVID-19).
Adyton Resources (TSX-V: ADY, OTCQB: ADYRF) Corporation announced the appointment of David Irvine to its board as an independent non-executive director effective December 31, 2021, subject to the approval of the Venture Exchange TSX, part of a board restructuring. The company also announced the appointment of existing directors, Sinton Spence and Tim Crossley, as chairman of the board and interim CEO, respectively. The new board of directors, made up of Spence and Crossley and new person named Irvine, will lead the company on an interim basis as it restructures its board of directors and management team.
Victory Square Technologies Inc (CSE: VST, OTCQX: VSQTF) announced that it has finalized the second tranche of its special common stock dividend in the capital of its holding company Immersive to shareholders. This second dividend represented approximately 4,500,000 Immersive shares, which, added to the 4,500,000 Immersive shares previously distributed by Victory Square to its shareholders earlier this year, represents a total of 9,000,000 Immersive shares distributed to Victory shareholders. Square. The second tranche dividend was completed on December 30, 2021. Prior to the completion of the second dividend, Victory Square held 57,588,520 Immersive shares representing 75.72% of the issued and outstanding shares and after the second dividend, Victory Square held 53,088,520 Immersive shares representing 69.81% of the issued and outstanding securities, in each case on an undiluted basis.
Eric Sprott announced that 2176423 Ontario Ltd, a company he beneficially owns, exercised 1,130,000 common share purchase warrants of Benchmark Metals Inc at a price of $ 0.40 per share for a total consideration of 452,000 $. The exercise of the warrants, combined with the previous share issues from the Company’s treasury, resulted in a decrease in holdings of approximately 3.1% of the outstanding Reference Shares on a partially diluted basis since the date. of the latest early warning report. Prior to the exercise of these warrants, Sprott beneficially owned and controlled 24,952,309 Reference Shares and 4,976,154 warrants representing approximately 12.4% of the outstanding shares on an undiluted basis and approximately 14.6%. % on a partially diluted basis assuming the exercise of all these warrants. Sprott now beneficially owns and controls 26,082,309 Reference Shares and 3,846,154 warrants representing approximately 12.9% of the outstanding shares on an undiluted basis and approximately 14.6% on a partially diluted basis assuming the ‘exercise of these warrants. The exercise of the warrants resulted in a partially diluted change in ownership of more than 2% and, as a result, the filing of an updated early warning report. The securities mentioned above are held for investment purposes. Sprott has a long-term view of investing and may acquire additional securities, including on the open market or through private acquisitions or sell the securities, including on the open market or through private disposals in the future in depending on market conditions, reformulation of plans and / or other relevant factors.
Plurilock Security Inc said it has entered into an online marketing agreement with AGORA Internet Relations Corp. Under the terms and conditions of the agreement, AGORA will assist the company in launching a 12 month online marketing campaign. AGORA will assist the company in the placement of ads and other branding initiatives that will be published on AGOROCOM and distributed on YouTube, various social media platforms and all podcast platforms. In connection with the services provided under the agreement, the company will pay AGORA aggregate consideration of $ 100,000 plus applicable taxes, which will be paid by the issuance of common shares in the capital of the company. The Payment Shares will be issued in five installments during the term of the AGORA Agreement, which begins January 1, 2022 and ends December 30, 2022, subject to approval by the TSX Venture Exchange.
NorthWest Copper (TSX-V: NWST) Corp announced that it has granted 3,575,000 stock options to directors, certain employees and consultants, and 1,175,000 restricted stock units (RSUs) to certain employees and consultants under its stock option and RSU plans. Stock options have an exercise price of $ 0.80 and have a vesting period range of three years and expire after five years. RSUs are payable in common shares of the Company on exercise, have a three-year vesting period, and must be redeemed within 30 days of December 29, 2024, or they expire.